Introduction
Bariticinib Real World Evidence
Objectives
"- Reinforce Benefit risk/profile of Olumiant using RWE & long-term data
- To present the most updated results on Baricitinib efficacy and safety for the management of patients with Rheumatoid Arthritis"
This Course For :
Physician
( Family Medicine , Internal Medicine , Rheumatology , General practitioner )
Resident / Fellow
( Family Medicine , Internal Medicine , Rheumatology , General practitioner )
Speaker
Rieke Alten
Professor of Medicine and Head of the Department of Internal Medicine, Rheumatology, Clinical Immunology, Osteology at Schlosspark-Klinik, University Medicine Berlin, where she also serves as the Director of the Rheumatology Research Center
Peter C. Taylor
Trained at Cambridge and Oxford Universities and gained a PhD from the University of London. He holds the Norman Collisson chair of musculoskeletal sciences at Oxford University where he is the Director of Clinical Sciences
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
21 Mar 2023 To 21 Mar 2023 -
07:00 PM To 08:00 PM 
Certificate Available 
Online Click Here
- 292
Add to Calendar
03/21/2023 07:00 PM
03/21/2023 08:00 PM
Asia/ Riyadh
Baricitinib in the Management of RA: From Clinical Evidence to Real World Experience
Baricitinib in the Management of RA: From Clinical Evidence to Real World Experience
https://medicalacademy.org/portal/event/view/1941
